| BSE: 500257 | Sector: Health care |
| NSE: LUPIN | ISIN Code: INE326A01037 |
| BSE 00:00 | 21 Sep | 889.75 |
-19.25 (-2.12%) |
OPEN
916.65 |
HIGH
931.50 |
LOW
851.00 |
| NSE 00:00 | 21 Sep | 890.25 |
-19.10 (-2.10%) |
OPEN
919.80 |
HIGH
931.50 |
LOW
853.60 |
| OPEN | 916.65 |
| PREVIOUS CLOSE | 909.00 |
| VOLUME | 388001 |
| 52-Week high | 1090.00 |
| 52-Week low | 723.55 |
| P/E | 28.33 |
| Mkt Cap.(Rs cr) | 40,230 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations biotechnology products and active pharmaceutical ingredients (APIs) globally. The company is a significant player in the Cardiovascular Diabetology Asthma Pediatric CNS GI Anti-Infective and NSAID space and holds global leadership position in the Anti-TB segment....> More
| Parameter | Values | ||
| Market Cap | ( cr) |
40,230 | |
| EPS - TTM | () |
[*S] | 31.41 |
| P/E Ratio | (X) | [*S] | 28.33 |
| Face Value | () |
2 | |
| Latest Dividend | (%) | 250.00 | |
| Latest Dividend Date | 30 Jul 2018 | ||
| Dividend Yield | (%) | 0.56 | |
| Book Value / Share | () |
[*S] | 349.11 |
| P/B Ratio | () |
[*S] | 2.55 |
Nifty Pharma index rises 2% as Sun Pharma, Lupin receive USFDA approval
Lupin's pneumonia drug Atovaquone oral suspension receives USFDA approval
Sun Pharma, Glenmark Pharma, Hikal hit 52-week highs; Aurobindo surges 8%
Nifty Pharma index set to post sharpest monthly rally in 9 years
Nifty Pharma index hits 52-week high; Cipla, Sun Pharma touch 52-week highs
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Appointment Of Dr. Sharma As Advisor To The Company For A Period Of One Year Effective October 1 201
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Particulars ( cr) |
Jun 2018 | Jun 2017 | % Chg |
| Net Sales | 3855.93 | 3869.58 | -0.35 |
| Other Income | 184.89 | 31.97 | 478.32 |
| Total Income | 4040.82 | 3901.55 | 3.57 |
| Total Expenses | 3328.96 | 3103.48 | 7.27 |
| Operating Profit | 711.86 | 798.07 | -10.8 |
| Net Profit | 203.02 | 356.85 | -43.11 |
| Equity Capital | 90.43 | 90.34 | - |
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Dr Reddy's Labs | 2562.90 | -1.57 | 42549.27 |
| Biocon | 676.10 | 1.01 | 40566.00 |
| Cadila Health. | 395.00 | -3.01 | 40436.15 |
| Lupin | 889.75 | -2.12 | 40230.05 |
| Divi's Lab. | 1386.05 | -0.23 | 36792.70 |
| Torrent Pharma. | 1727.95 | -1.50 | 29240.37 |
| Glaxosmi. Pharma | 1623.55 | -1.65 | 27504.56 |
|
|
|
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | -7.93% | -8.10% | -3.28% | -3.23% |
| 1 Month | 0.06% | 0.19% | -3.77% | -3.70% |
| 3 Month | -1.01% | -1.04% | 3.98% | 3.74% |
| 6 Month | 15.88% | 15.94% | 11.18% | 9.73% |
| 1 Year | -13.82% | -13.60% | 13.81% | 10.09% |
| 3 Year | -52.70% | -52.66% | 40.65% | 39.69% |
| Today's Low/High | 851.00 |
|
931.50 |
| Week Low/High | 851.00 |
|
980.00 |
| Month Low/High | 851.00 |
|
986.00 |
| YEAR Low/High | 723.55 |
|
1090.00 |
| All TIME Low/High | 0.80 |
|
2127.00 |
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
Other
Details
